Uptake of FITC-chitosan nanoparticles by a549 cells

被引:355
作者
Huang, M
Ma, ZS
Khor, E
Lim, LY
机构
[1] Natl Univ Singapore, Dept Pharm, Singapore 117543, Singapore
[2] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore
关键词
chitosan; nanoparticles; A549; cells; FITC; uptake;
D O I
10.1023/A:1020404615898
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The objective of this study was to evaluate the extent and mechanism of uptake of fluorescent chitosan nanoparticles by the A549 cells, a human cell line derived from the respiratory epithelium. Methods. Covalent conjugation with fluorescein-5-isothiocyanate yielded stably labeled chitosan molecules, which were successfully formulated into nanoparticles by ionotropic gelation. Uptake of fluorescein-5-isothiocyanate-chitosan nanoparticles and chitosan molecules by confluent A549 cells was quantified by fluorometry. Results. Cellular uptake of chitosan nanoparticles was concentration and temperature dependent, having K-m and V-max of 3.84 muM and 58.14 mug/mg protein/h, respectively. Uptake of chitosan nanoparticles was up to 1.8-fold higher than that of chitosan molecules alone and was not inhibited by excess unlabeled chitosan molecules. Hyperosmolarity, chlorpromazine and K+ depletion inhibited by 65, 34, and 54%, respectively, the uptake of chitosan nanoparticles at 37degreesC, but filipin had no influence on the uptake. Confocal imaging confirmed the internalization of the chitosan nanoparticles by the A549 cells at 37degreesC. Conclusions. Formulation of chitosan into nanoparticles significantly improved its uptake by the A549 cells. Internalization of chitosan nanoparticles by the cells seems to occur predominantly by adsorptive endocytosis initiated by nonspecific interactions between nanoparticles and cell membranes, and was in part mediated by clathrin-mediated process.
引用
收藏
页码:1488 / 1494
页数:7
相关论文
共 31 条
  • [1] Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO
  • [2] 2-4
  • [3] INHIBITION OF RECEPTOR-MEDIATED BUT NOT FLUID-PHASE ENDOCYTOSIS IN POLYMORPHONUCLEAR LEUKOCYTES
    DAUKAS, G
    ZIGMOND, SH
    [J]. JOURNAL OF CELL BIOLOGY, 1985, 101 (05) : 1673 - 1679
  • [4] Evaluation of nano- and microparticle uptake by the gastrointestinal tract
    Delie, F
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1998, 34 (2-3) : 221 - 233
  • [5] Haffejee N, 2001, PHARMAZIE, V56, P882
  • [6] CHITOSAN AS A NOVEL NASAL DELIVERY SYSTEM FOR PEPTIDE DRUGS
    ILLUM, L
    FARRAJ, NF
    DAVIS, SS
    [J]. PHARMACEUTICAL RESEARCH, 1994, 11 (08) : 1186 - 1189
  • [7] Chitosan as a novel nasal delivery system for vaccines
    Illum, L
    Jabbal-Gill, I
    Hinchcliffe, M
    Fisher, AN
    Davis, SS
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2001, 51 (1-3) : 81 - 96
  • [8] Chitosan nanoparticles as delivery systems for doxorubicin
    Janes, KA
    Fresneau, MP
    Marazuela, A
    Fabra, A
    Alonso, MJ
    [J]. JOURNAL OF CONTROLLED RELEASE, 2001, 73 (2-3) : 255 - 267
  • [9] Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?
    Jung, T
    Kamm, W
    Breitenbach, A
    Kaiserling, E
    Xiao, JX
    Kissel, T
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) : 147 - 160
  • [10] Chitosan for enhanced intestinal permeability:: Prospects for derivatives soluble in neutral and basic environments
    Kotzé, AF
    Luessen, HL
    de Boer, AG
    Verhoef, JC
    Junginger, HE
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 7 (02) : 145 - 151